| Click on table headings to change sort order. |
|
| 602115-00 | | View | | In-Depth Analysis of the Whole Human Mitochondrial Genome for Pathogenic Mutations And Variants By DHPLC, SURVEYOR® Nuclease and DNA Sequencing: A Cost-Effective Multi-Pronged Approach for Clinical Labs |
| 602125-00 | | View | | In-Depth Screening of Polymerase Gamma 1 gene with DHPLC, SURVEYOR® Nuclease strategy and DNA sequencing |
| 602126-00 | | View | | Heterozygous mutations in BCS1L gene: A clinical case of Bjornstad syndrome |
| 602127-00 | | View | | Mutation analysis of VLCAD gene in neonates – a sensitive and cost effective tiered approach
|
| 602128-00 | | View | | Analysis of SCN1A gene for pathogenic mutations in Severe myoclonic epilepsy of infancy (SMEI) by DHPLC, SURVEYOR® Nuclease and DNA sequencing: A sensitive efficient clinical approach |
| 482212-01 | | View | | CASE STUDY: A Study of Cancer Pathway Genes- A diagnostic assessment of tumor suppressor gene TP53 in circulating DNA in various types of cancer |
| 482216-00 | | View | | CASE STUDY: DISCOVERY OF NOVEL MUTATIONS — Expertise in Candidate Gene Analysis Helps Scientists Identify Illusive Mutations in SCCD Patients |
| 482225-00 | | View | | OPA1 Mutations involved in mitochondrial instability resulting in multisystem mitochondrial disorders |
| 482233-00 | | View | | Analysis Of Von Hippel-lindau Tumor Suppressor Gene Mutations In Clear Cell RCC Tumors Using Multiple Platforms: An In-depth Mutation Screening Strategy |
